REGISTERED
on 24 Jan 2023
Last Applicant/ Owned by
69120 Heidelberg
DE
Serial Number
79314148 filed on 10th Apr 2021
Registration Number
6959288 registered on 24th Jan 2023
Correspondent Address
Sean K. Owens
Filing Basis
No Filing Basis
Disclaimer
NO DATA
H.F.M BY TICEBA
The color(s) blue and green is/are claimed as a feature of the mark. The mark consists of the wording "H.F.M.", underlined and above the wording "BY TICEBA", all in the color blue. The wording is surrounded by 8 rods having a small ball at each end and alternating in color, with every other one in the color blue and the others in the color green. The color white represents background, outlining, Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services relating to the removal, treatment, processing and preservation of medical cells and human tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment and processing of human tissue and stem cells, human tissue and stem cell bank services, including in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells
Class [042]
Computer & Software Services & Scientific Services
Stem cell research; scientific research and development and medical research and development in the field of stem cells; Scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering; Scientific research for medical purposes; Medical research; Research and development of new products for others; Consultancy in the field of pharmaceutical research; Providing information on medical and scientific research on pharmaceutical products; Biomedical research; Preparation of reports relating to scientific research, namely, technical writing for others; Research in the field of biotechnology; Research in the field of gene therapy; Research and development in the field of immunology; Research and development in the field of antibodies; Research and development in the field of antibody technology; Research and development in the field of bacteriology; Research and development in the field of gene expression systems; Research and development in the field of vaccines; Research and development services for the pharmaceutical industry; Research and development services in the field of biotechnology; Development of industrial processes, namely, engineering of industrial processes to manufacture stem cells; Development of industrial processes, namely, in the field of regenerative medicine and tissue engineering;Industrial process research in the field of regenerative medicine, tissue engineering, chemical engineering
Class [001]
Chemical Products
Stem cells for scientific or research use; cell growth media for growing cells for scientific use
Class [005]
Pharmaceutical Products
Pharmaceutical drugs, namely, pharmaceutical drugs for treatment of skin diseases, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; Pharmaceutical drugs for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, the reproductive system, for the treatment of blood diseases and disorders; Pharmaceutical and veterinary preparations for treatment of vertigo, migraine, nausea, vomiting, for treatment of skin diseases, wound healing; Pharmaceutical preparations for anti-aging; Diagnostic agents for medical use; Preparations for medical purposes, namely, for the treatment of skin diseases; Substances for medical use, namely, for regeneration of tissue and anti-inflammation; Stem cells for medical purposes; Stem cells for veterinary purposes; Stem cells for aesthetic purposes, namely, for anti-aging, for use in dermatology procedures; Somatic stem cell therapeutics, namely, for medical therapeutic use; Fibroblasts for medical use; Fibroblasts for aesthetic purposes, namely, for use in dermatology procedures; Pharmaceutical implants, namely, implantable surgery bones, bone grafts, cells, bone marrow; Surgical implants derived from stem cells, namely, surgical implants derived from living tissues and living stem cells; Surgical implants derived from fibroblasts, namely, surgical implants comprised of living fibroblasts tissue cells; Biological tissue for implantation, namely, implants comprising living tissues; Cell growth media for growing cells for medical use; Pharmaceutical preparations for tissue regeneration; Vascular grafts; Living tissue, namely, surgical implants comprised of living tissues; Biotechnologically engineered tissue products, namely, cell sheets/plasters for wound healing/burns, eye lense grafts, bone grafts, biological tissue grafts, human allograft tissue
Mark Details
Serial Number
No 79314148
Mark Type
No Service Mark
Attorney Docket Number
No MREC-05
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
26.17.13 -
Letters or words underlined and/or overlined by one or more strokes or lines
Description of Design Search
The mark consists of the wording "H.F.M.", underlined and above the wording "BY TICEBA", all in the color blue. The wording is surrounded by 8 rods having a small ball at each end and alternating in color, with every other one in the color blue and the others in the color green. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd May 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 01st May 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 01st May 2023 | FINAL DISPOSITION PROCESSED |
| 24th Apr 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 24th Jan 2023 | REGISTERED-PRINCIPAL REGISTER |
| 24th Jan 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 20th Dec 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 30th Nov 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 30th Nov 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 08th Nov 2022 | PUBLISHED FOR OPPOSITION |